BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28895414)

  • 1. Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/β-catenin signaling pathway.
    Deng B; Zhang S; Zhang Y; Miao Y; Meng X; Guo K
    Neoplasma; 2017; 64(6):893-900. PubMed ID: 28895414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
    Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of FOXC1 Promotes Tumor Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer.
    Sun Y; Lin C; Ding Q; Dai Y
    Dig Dis Sci; 2022 Aug; 67(8):3742-3752. PubMed ID: 34427817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
    Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway.
    Xu Q; Li X; Li Y; Yu J; Yang A
    Funct Integr Genomics; 2023 May; 23(2):154. PubMed ID: 37162618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
    Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
    Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
    Hu C; Dong T; Li R; Lu J; Wei X; Liu P
    Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of CEMIP suppresses Wnt/β-catenin/Snail signaling transduction and inhibits EMT program of colorectal cancer cells.
    Liang G; Fang X; Yang Y; Song Y
    Acta Histochem; 2018 Jan; 120(1):56-63. PubMed ID: 29173982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling.
    Zhang L; Chen J; Chen Y; Zou D; Pu Y; Wei M; Huang Y; Li Y; Huang Q; Chen J
    Anticancer Agents Med Chem; 2023; 23(1):94-104. PubMed ID: 35598249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.
    Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W
    Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway.
    Gao LN; Hao M; Liu XH; Zhang L; Dong Y; Zhang YF; He XC
    J Ovarian Res; 2021 Nov; 14(1):159. PubMed ID: 34789307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
    Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
    Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBP43 promotes epithelial ovarian carcinogenesis via activation of β-catenin signaling pathway.
    Xie H; Chen J; Ma C; Zhao J; Cui M
    Cell Biol Int; 2023 Aug; 47(8):1427-1440. PubMed ID: 37186433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling.
    Bernaudo S; Salem M; Qi X; Zhou W; Zhang C; Yang W; Rosman D; Deng Z; Ye G; Yang BB; Vanderhyden B; Wu Z; Peng C
    Oncogene; 2016 Sep; 35(36):4816-27. PubMed ID: 26876206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.